Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis

Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysisAssociation between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis, Published online: 24 September 2018; doi:10.1038/s41397-018-0054-0Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis

Source: The Pharmacogenomics Journal - September 24, 2018 Category: Drugs & Pharmacology Authors: Qian Xiang Shu-qing Chen Ling-yue Ma Kun Hu Zhuo Zhang Guang-yan Mu Qiu-fen Xie Xiao-dan Zhang Yi-min Cui Source Type: research